Minerva Neurosciences reported $-6901000 in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
ALKERMES ALKS:US USD 136K 7.25M
AstraZeneca AZN:LN USD 3.09B 52M
Eli Lilly And LLY:US USD 2.04B 38.3M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Halozyme Therapeutics HALO:US USD 73.71M 21.78M
IONIS PHARMACEUT IONS:US USD -47000000 56M
Johnson & Johnson JNJ:US USD 7.42B 655M
Marinus Pharmaceuticals MRNS:US USD 75.04M 114.48M
Merk MRK:US USD 4.89B 560M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Neurocrine Biosciences NBIX:US USD 117.9M 20M
Novartis NOVN:VX USD 3.86B 195M
Novavax NVAX:US USD -166141000 342.93M
Pfizer PFE:US USD 7.38B 3.3B
Roche Holding ROG:VX 12.11B 2.43B
Sanofi SAN:FP EUR 2.75B 1.68B
Takeda 4502:JP JPY 107.15B 42.6B
Vanda Pharmaceuticals VNDA:US USD 5.46M 1.67M